[PETGAS] QoQ Annualized Quarter Result on 30-Sep-2024 [#3]

Announcement Date
27-Nov-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Sep-2024 [#3]
Profit Trend
QoQ- 2.22%
YoY- 3.0%
View:
Show?
Annualized Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 6,563,741 6,533,764 6,475,236 6,445,423 6,483,449 6,624,626 6,699,780 -1.35%
PBT 2,515,741 2,424,174 2,389,384 2,386,015 2,370,050 2,366,108 2,227,748 8.41%
Tax -509,818 -497,694 -500,208 -484,976 -456,150 -477,580 -434,576 11.20%
NP 2,005,922 1,926,480 1,889,176 1,901,039 1,913,900 1,888,528 1,793,172 7.73%
-
NP to SH 1,892,417 1,851,280 1,826,588 1,819,600 1,837,345 1,819,100 1,696,708 7.52%
-
Tax Rate 20.27% 20.53% 20.93% 20.33% 19.25% 20.18% 19.51% -
Total Cost 4,557,818 4,607,284 4,586,060 4,544,384 4,569,549 4,736,098 4,906,608 -4.78%
-
Net Worth 13,852,201 13,735,763 13,589,931 13,555,105 13,477,736 13,325,177 13,143,925 3.55%
Dividend
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Div 1,319,125 1,266,388 1,266,388 1,424,687 1,319,154 1,266,388 1,266,388 2.74%
Div Payout % 69.71% 68.41% 69.33% 78.30% 71.80% 69.62% 74.64% -
Equity
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Net Worth 13,852,201 13,735,763 13,589,931 13,555,105 13,477,736 13,325,177 13,143,925 3.55%
NOSH 1,978,687 1,978,732 1,978,732 1,978,732 1,978,732 1,978,732 1,978,732 -0.00%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 30.56% 29.48% 29.18% 29.49% 29.52% 28.51% 26.76% -
ROE 13.66% 13.48% 13.44% 13.42% 13.63% 13.65% 12.91% -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 331.72 330.20 327.24 325.74 327.66 334.79 338.59 -1.35%
EPS 95.64 93.56 92.32 91.96 92.85 91.94 85.76 7.51%
DPS 66.67 64.00 64.00 72.00 66.67 64.00 64.00 2.75%
NAPS 7.0007 6.9417 6.868 6.8504 6.8113 6.7342 6.6426 3.55%
Adjusted Per Share Value based on latest NOSH - 1,978,649
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 331.73 330.21 327.26 325.75 327.67 334.81 338.60 -1.35%
EPS 95.64 93.56 92.31 91.96 92.86 91.94 85.75 7.52%
DPS 66.67 64.00 64.00 72.00 66.67 64.00 64.00 2.75%
NAPS 7.0008 6.942 6.8683 6.8507 6.8116 6.7345 6.6429 3.55%
Price Multiplier on Financial Quarter End Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 30/09/24 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 -
Price 18.00 17.82 17.62 17.40 16.84 16.70 16.48 -
P/RPS 5.43 5.40 5.38 5.34 5.14 4.99 4.87 7.50%
P/EPS 18.82 19.05 19.09 18.92 18.14 18.17 19.22 -1.38%
EY 5.31 5.25 5.24 5.28 5.51 5.50 5.20 1.40%
DY 3.70 3.59 3.63 4.14 3.96 3.83 3.88 -3.10%
P/NAPS 2.57 2.57 2.57 2.54 2.47 2.48 2.48 2.39%
Price Multiplier on Announcement Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 27/11/24 20/08/24 29/05/24 27/02/24 20/11/23 25/08/23 22/05/23 -
Price 17.74 18.18 18.30 18.06 17.18 17.06 16.94 -
P/RPS 5.35 5.51 5.59 5.54 5.24 5.10 5.00 4.60%
P/EPS 18.55 19.43 19.82 19.64 18.50 18.56 19.76 -4.11%
EY 5.39 5.15 5.04 5.09 5.40 5.39 5.06 4.28%
DY 3.76 3.52 3.50 3.99 3.88 3.75 3.78 -0.35%
P/NAPS 2.53 2.62 2.66 2.64 2.52 2.53 2.55 -0.52%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment